275
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Formulation and evaluation of gastroretentive floating drug delivery system of dipyridamole

, , , , , & show all
Pages 674-680 | Received 10 Nov 2013, Accepted 06 Feb 2014, Published online: 04 Mar 2014

References

  • Chakrabarti S, Freedman JE. Dipyridamole, cerebrovascular disease and the vasculature. Vascul Pharmacol 2008;48:143–9
  • Zhang Z, Peng B, Yang X, et al. Design and evaluation of a novel floating osmotic pump system. J Pharm Sci 2009;12:129–37
  • Guo F, Zhong H, He J, et al. Self-microemulsifying drug delivery system for improved oral bioavailability of dipyridamole: preparation and evaluation. Arch Pharm Res 2011;34:1113–23
  • Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics. Drug Dev Ind Pharm 2001;27:507–15
  • Xu L, Luo Y, Feng J, et al. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability. Int J Pharm 2012;422:9–16
  • Gursoy A, Karakus D, Okar I. Polymers for sustained release formulations of dipyridamole-alginate microspheres and tabletted microspheres. J Microencapsul 1999;16:439–52
  • Chen S, Zhu J, Ma F, et al. Preparation and characterization of solid dispersions of dipyridamole with a carrier “copolyvidonum Plasdone S-630”. Drug Dev Ind Pharm 2007;33:888–99
  • Patel VF, Patel NM. Statistical evaluation of influence of xanthan gum and guar gum blends on dipyridamole release from floating matrix tablets. Drug Dev Ind Pharm 2007;33:327–34
  • Adebisi A, Conway BR. Gastroretentive microparticles for drug delivery applications. J Microencapsul 2011;28:689–708
  • Kotreka UK, Adeyeye MC. Gastroretentive floating drug-delivery systems: a critical review. Crit Rev Ther Drug Carrier Syst 2011;28:47–99
  • Thakar K, Joshi G, Sawant KK. Bioavailability enhancement of baclofen by gastroretentive floating formulation: statistical optimization, in vitro and in vivo pharmacokinetic studies. Drug Dev Ind Pharm 2013;39:880–8
  • Rapolu K, Sanka K, Vemula PK, et al. Optimization and characterization of gastroretentive floating drug delivery system using Box–Behnken design. Drug Dev Ind Pharm 2013;39:1928–35
  • Streubel A, Siepmann J, Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci 2003;18:37–45
  • Umamaheshwari RB, Jain S, Bhadra D, Jain NK. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol 2003;55:1607–13
  • Bhadouriya P, Kumar M, Pathak K. Floating microspheres: to prolong the gastric retention time in stomach. Curr Drug Deliv 2012;9:315–24
  • Talukder R, Fassihi R. Gastroretentive delivery systems: a mini review. Drug Dev Ind Pharm 2004;30:1019–28
  • Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J Control Release 2005;107:300–9
  • Sriamornsak P, Sungthongjeen S, Puttipipatkhachorn S. Use of pectin as a carrier for intragastric floating drug delivery: carbonate salt contained beads. Carbohyd Polym 2007;67:436–45
  • Gupta R, Pathak K. Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine. Drug Dev Ind Pharm 2008;34:1201–8
  • Goswami N, Joshi G, Sawant K. Floating microspheres of valacyclovir HCl: formulation, optimization, characterization, in vitro and in vivo floatability studies. J Pharm Bioallied Sci 2012;4:8–9
  • Vaghani S, Vasanti S, Chaturvedi K, et al. Stomach-specific drug delivery of 5-fluorouracil using ethylcellulose floating microspheres. Pharm Dev Technol 2010;5:154–61
  • Al-Musa S, Abu FD, Badwan AA. Evaluation of parameters involved in preparation and release of drug loaded in cross-linked matrices of alginate. J Control Release 1999;57:223–32
  • Kikuchi A, Kawabuchi M, Watanabe A, et al. Effect of Ca2+-alginate gel dissolution on release of dextran with different molecular weights. J Control Release 1999;58:21–8
  • Yuan P, Jia Y, Zhang L, et al. Swelling studies and in vitro release of acemetacin and BSA from alginate gel beads cross-linked with Ca2+ or Ba2+. J Wuhan Univ Technol: Mater Sci 2012;27:669–74
  • Hua S, Yang H, Li Q, et al. PH-sensitive sodium alginate/calcined hydrotalcite hybrid beads for controlled release of diclofenac sodium. Drug Dev Ind Pharm 2012;38:728–34
  • Smrdel P, Bogataj M, Podlogar F, et al. Characterization of calcium alginate beads containing structurally similar drugs. Drug Dev Ind Pharm 2006;32:623–33
  • Anal AK, Bhopatkar D, Tokura S, et al. Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm 2003;29:713–24
  • Talukder R, Fassihi R. Gastroretentive delivery systems: hollow beads. Drug Dev Ind Pharm 2004;30:405–12
  • Tang YD, Venkatraman SS, Boey FY, Wang LW. Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form. Int J Pharm 2007;336:159–65
  • Ma N, Xu L, Wang Q, et al. Development and evaluation of new sustained-release floating microspheres. Int J Pharm 2008;358:82–90
  • Yao H, Yao H, Zhu J, et al. Preparation and evaluation of a novel gastric floating alginate/poloxamer inner-porous beads using foam solution. Int J Pharm 2012;422:211–19
  • Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008;60:1638–49
  • Matricardi P, Meo CD, Coviello T, Alhaique F. Recent advances and perspectives on coated alginate microspheres for modified drug delivery. Expert Opin Drug Deliv 2008;5:417–25
  • Tonnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002;28:621–30
  • Cetin M, Atila A, Kadioglu Y. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech 2010;11:1250–6
  • Maghsoodi M. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100. AAPS PharmSciTech 2009;10:120–8
  • Pirayavaraporn C, Rades T, Tucker IG. Determination of moisture content in relation to thermal behaviour and plasticization of Eudragit RLPO. Int J Pharm 2012;422:68–74
  • Sahoo J, Murthy PN, Biswal S, Manik. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR. AAPS PharmSciTech 2009;10:27–33
  • Kim JS, Kim MS, Park HJ, et al. Statistical optimization of tamsulosin hydrochloride controlled release pellets coated with the blend of HPMCP and HPMC. Chem Pharm Bull 2007;55:936–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.